Dextenza® (dexamethasone ophthalmic insert) – Expanded indication
April 7, 2025 - The FDA approved Ocular Therapeutix’s Dextenza (dexamethasone ophthalmic insert), for the treatment of Ocular inflammation and pain following ophthalmic surgery in adults and pediatric patients; and Ocular itching associated with allergic conjunctivitis in adults and pediatric patients aged 2 years and older.
Top